Enterprise Evidence Report · NR-REPORT-V2.0

Pakistan
Neuroscience Intelligence

Pakistan neuroscience evidence report: current clinical, research, institution and source-linked intelligence.

Evidence rank #38 of 50 · Data maturity A · Research score 30.9 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.

⚗
60Curated trials
↗
17Recruiting trials
▦
28Publications
⌂
38Institutions

Executive interpretation

Pakistan ranks #38 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.

Methodology status

Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.

Methodology →

Leading sponsors

Riphah International University359 recruiting
Pakistan Institute of Living and Learning31 recruiting
Khyber Medical University Peshawar22 recruiting
Foundation University Islamabad21 recruiting
Ziauddin University21 recruiting
Lahore University of Biological and Applied Sciences20 recruiting
Shaheed Zulfiqar Ali Bhutto Medical University20 recruiting
Pakistan Air Force (PAF) Hospital Islamabad10 recruiting
Peshawar Medical College10 recruiting
Shifa Tameer-e-Millat University11 recruiting

Disease activity

Autism21trials
Stroke9trials
Pain Neuropathy7trials
Parkinsons6trials
Epilepsy3trials
Cerebral Palsy3trials
Depression3trials
Other Neurology2trials
Adhd2trials
Intellectual Disability1trials

Research institutions

Karachi Medical and Dental CollegeOpenAlexlinked institution
University of Agriculture FaisalabadOpenAlexlinked institution
Abdul Wali Khan University MardanOpenAlexlinked institution
University of Health Sciences LahoreOpenAlexlinked institution
Human Development Research FoundationOpenAlexlinked institution
Khyber Medical UniversityOpenAlexlinked institution
University of GujratOpenAlexlinked institution
COMSATS University IslamabadOpenAlexlinked institution
Civil Hospital KarachiOpenAlexlinked institution

Clinical evidence trail

NCT07801586Additional Effects of Pain Neuroscience Education With Standard Pre-operative Physiotherapy on Post-laminectomy Pain and Disability.RECRUITING
NCT07786545Pilot Evaluation of the Developed Syntactic-Semantic Visual Configuration Intervention for Children With Language ImpairmentNOT_YET_RECRUITING
NCT07722949Feasibility of a Culturally Adapted Nurse-Led COPE Intervention for Caregivers of Children With Autism Spectrum DisorderRECRUITING
NCT07673263Effects of X Box Kinect 360 in Alzheimer's DiseaseNOT_YET_RECRUITING
NCT07665658Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in ChildrenRECRUITING
NCT07629856Effect of Cognitive-Motor Dual-Task Training on Postural Stability and Functional Mobility in StrokeNOT_YET_RECRUITING
NCT07578987Effects of Kinetic Sand on Functional Reach and Eye-Hand Coordination in Children With AutismRECRUITING
NCT07575113Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic NeuropathyNOT_YET_RECRUITING
NCT07570550Effectiveness of Parent-Mediated Intervention Combined With Positive Behavioral Support on Challenging Behaviors and Parenting Stress Among Children With Autism.ACTIVE_NOT_RECRUITING
NCT07484451Effects Of Strategy Training And PNF On Balance, Gait, And Independence In Parkinson's DiseaseNOT_YET_RECRUITING
NCT07438665Toe Spread Out Exercise With and Without Walking Surface Training in Children With AutismNOT_YET_RECRUITING
NCT07428824Effects Of Functional Action Observation With Auditory Cueing In Stroke PatientsRECRUITING

Research evidence trail

PUBMEDIntermittent theta-burst stimulation versus sham stimulation for suicidal ideation and psychiatric symptoms in depressive disorders: A systematic review and meta-analysis of randomized controlled trials.2026-12-01
PUBMEDAdverse-effect burden as the dominant correlate of antidepressant non-adherence in major depressive disorder: insights from a multicentre machine-learning analysis.2026-12-01
PUBMEDAnalyzing the Role of Essential Minerals in Neuropsychiatric Health: A Comparative Assessment of Depressed Versus Healthy Individuals.2026-10-01
PUBMEDSudan's Silent Mental Health Crisis: A Systemic Failure of Humanitarian Response.2026-09-24
PUBMEDGrowth and Neurodevelopmental Outcomes of Children With Congenital Hypothyroidism Identified Through Dried Blood Spot Newborn Screening at a Tertiary Care Hospital in Pakistan.2026-09-01
PUBMEDThe Predictive Role of Personality Disorders and Personality Traits in Death Anxiety.2026-09-01
PUBMEDWhole-exome sequencing reveals a novel frameshift and a recurrent nonsense SPG11 variant causing rare familial amyotrophic lateral sclerosis type 5 in two consanguineous Pakistani families.2026-09-01
PUBMEDCSF Tau and Amyloid Biomarkers in Cognitive Impairment Across the ALS-FTD Spectrum: A Systematic Narrative Review and Evidence Map.2026-09-01
PUBMEDA quarter-century mortality analysis of concomitant infective endocarditis and stroke in the United States - A nationwide CDC WONDER study.2026-09-01
PUBMEDHereditary neurodegenerative disorders with spastic-ataxic manifestations: genetic and clinical insights into previously reported variants.2026-08-31
PUBMEDSurveillance for neurodevelopmental impairment (NDI) in high-risk neonates: a cohort study at a tertiary care hospital in Pakistan.2026-08-12
PUBMED"Comment on: Mid-long term efficacy of dihydroergotoxine mesylate in treatment of sialorrhea in Parkinson's disease".2026-07-01

World Bank context

IT.NET.USER.ZSinternet_users_pct57.3% · 2024
NY.GDP.MKTP.CDgdp_current_usd$407.3B · 2025
NY.GDP.PCAP.CDgdp_per_capita_usd$1,596 · 2025
SE.PRM.ENRRschool_enrollment_primary_pct83.73 · 2024
SE.SEC.ENRRschool_enrollment_secondary_pct48.28 · 2024
SH.XPD.CHEX.GD.ZScurrent_health_expenditure_pct_gdp2.5% · 2023
SH.XPD.CHEX.PC.CDcurrent_health_expenditure_per_capita_usd$30 · 2023
SH.XPD.GHED.GD.ZSgovernment_health_expenditure_pct_gdp0.9% · 2023
SP.DYN.CBRT.INbirth_rate_crude27.41 · 2024
SP.POP.TOTLpopulation_total255,219,554 · 2025
SP.URB.TOTL.IN.ZSurban_population_pct39.5% · 2025

Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.

Sources and provenance

ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.

Limitations

Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.